[go: up one dir, main page]

UY24913A1 - 2,4-DIAMINOPYRIMIDINE SUBSTITUTED - Google Patents

2,4-DIAMINOPYRIMIDINE SUBSTITUTED

Info

Publication number
UY24913A1
UY24913A1 UY24913A UY24913A UY24913A1 UY 24913 A1 UY24913 A1 UY 24913A1 UY 24913 A UY24913 A UY 24913A UY 24913 A UY24913 A UY 24913A UY 24913 A1 UY24913 A1 UY 24913A1
Authority
UY
Uruguay
Prior art keywords
preparation
compounds
substances
drugs
salts
Prior art date
Application number
UY24913A
Other languages
Spanish (es)
Inventor
Pierre-Charles Wyss
Jean-Luc Specklin
Synese Jolidon
Christian Hubschwerlen
Philippe Guerry
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of UY24913A1 publication Critical patent/UY24913A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

La invención se refiere a compuestos derivados de 2,4-diamino pirimidina sustituida. El empleo de estos compuestos y sus sales como sustancias terapéuticamente activas, medicamentos basados en estas sustancias y su elaboración, el empleo de estas substancias como medicamentos y para la elaboración de medicamentos antibacterialmente activos, así como también la preparación de dichos compuestos y sus sales farmacéuticamente aceptables y productos intermedios para su preparación. Se trata de compuestos de fórmula l (como por ejemplo: (E)-(RS)-3-[5-(2,4-diamino-pirimidin-5-ilmetil)-2,3-dimetoxi-fenil]-1-(1-fenil-1H-ftalazin-2-il)-propenona), en donde R1 significa alcoxilo inferior; R2 significa hidroxilo o alcoxilo inferior; R3 se selecciona entre H, CN, alquilo, inferior, alquenilo, cicloalquilo, biciclilo, arilo, heterociclialquilo; así como sus sales farmacéuticamente aceptables de los mismos.The invention relates to compounds derived from substituted 2,4-diamino pyrimidine. The use of these compounds and their salts as therapeutically active substances, drugs based on these substances and their preparation, the use of these substances as drugs and for the preparation of antibacterially active drugs, as well as the preparation of said compounds and their salts pharmaceutically acceptable and intermediate products for their preparation. These are compounds of formula l (such as: (E) - (RS) -3- [5- (2,4-diamino-pyrimidin-5-ylmethyl) -2,3-dimethoxy-phenyl] -1- (1-phenyl-1H-phthalazin-2-yl) -propenone), where R1 is lower alkoxy; R2 signifies hydroxyl or lower alkoxy; R3 is selected from H, CN, lower alkyl, alkenyl, cycloalkyl, bicyclyl, aryl, heterocyclyl alkyl; as well as their pharmaceutically acceptable salts thereof.

UY24913A 1997-03-03 1998-03-02 2,4-DIAMINOPYRIMIDINE SUBSTITUTED UY24913A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97103436 1997-03-03

Publications (1)

Publication Number Publication Date
UY24913A1 true UY24913A1 (en) 2001-01-31

Family

ID=8226543

Family Applications (1)

Application Number Title Priority Date Filing Date
UY24913A UY24913A1 (en) 1997-03-03 1998-03-02 2,4-DIAMINOPYRIMIDINE SUBSTITUTED

Country Status (21)

Country Link
US (1) US6114330A (en)
JP (1) JP4174077B2 (en)
KR (1) KR20000075888A (en)
CN (1) CN1091109C (en)
AR (1) AR011879A1 (en)
AT (1) ATE241618T1 (en)
AU (1) AU726836B2 (en)
BR (1) BR9808135A (en)
CA (1) CA2281642C (en)
CO (1) CO4940508A1 (en)
DE (1) DE69815072T2 (en)
DK (1) DK0966464T3 (en)
ES (1) ES2198705T3 (en)
HR (1) HRP980110A2 (en)
MA (1) MA26475A1 (en)
PE (1) PE59699A1 (en)
PT (1) PT966464E (en)
TR (1) TR199902140T2 (en)
TW (1) TW464648B (en)
UY (1) UY24913A1 (en)
ZA (1) ZA981529B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006523620A (en) * 2003-02-19 2006-10-19 バイオヴェイル ラボラトリーズ インコーポレイテッド Rapid absorption selective 5-HT agent formulation
US8268825B2 (en) * 2005-09-26 2012-09-18 The Board Of Regents For Oklahoma State University Method for the treatment of anthrax infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3117721B2 (en) * 1994-11-24 2000-12-18 エフ・ホフマン−ラ ロシュ アーゲー New benzyl pyrimidines
TW438796B (en) * 1996-05-15 2001-06-07 Hoffmann La Roche 2,4-diaminopyrimidine derivatives, the manufacture process thereof, and the antibiotically-active pharmaceutical composition containing the same

Also Published As

Publication number Publication date
TR199902140T2 (en) 2000-04-21
JP2001513791A (en) 2001-09-04
CO4940508A1 (en) 2000-07-24
AU6823198A (en) 1998-09-22
DE69815072T2 (en) 2004-04-01
ATE241618T1 (en) 2003-06-15
DE69815072D1 (en) 2003-07-03
AU726836B2 (en) 2000-11-23
CA2281642A1 (en) 1998-09-11
CA2281642C (en) 2008-02-05
US6114330A (en) 2000-09-05
BR9808135A (en) 2000-03-28
HRP980110A2 (en) 1998-12-31
CN1091109C (en) 2002-09-18
MA26475A1 (en) 2004-12-20
TW464648B (en) 2001-11-21
ES2198705T3 (en) 2004-02-01
CN1249751A (en) 2000-04-05
PE59699A1 (en) 1999-06-16
PT966464E (en) 2003-09-30
ZA981529B (en) 1998-09-03
AR011879A1 (en) 2000-09-13
DK0966464T3 (en) 2003-09-22
KR20000075888A (en) 2000-12-26
JP4174077B2 (en) 2008-10-29

Similar Documents

Publication Publication Date Title
CO4810373A1 (en) ARYL-CONDENSED AZAPOLYCLIC COMPOUNDS
ECSP045229A (en) PIRIDINONES REPLACED AS MODULATORS OF THE P38 MAP QUINASA
GT200100137A (en) PRO-DRUGS OF 4-PHENYL-PYRIDINE DERIVATIVES.
AR008861A1 (en) ARALQUILO AND ARALQUILEDENO LETAMIC AND IMIDA LACTAM COMPOUNDS, INTERMEDIARY COMPOUNDS FOR YOUR SYNTHESIS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
PA8431301A1 (en) METALOPROTEINASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR PHARMACEUTICAL USES AND USEFUL METHODS AND INTERMEDIATES FOR THEIR PREPARATION
UY26872A1 (en) DERIVATIVES OF THE 4- PIRIDINE PHENYL
PE20021019A1 (en) SUBSTITUTED AZABYCLE GROUPS
ES2161290T3 (en) DERIVATIVES OF QUINAZOLINA.
NO993350L (en) Vitronectin receptor antagonists
AR007118A1 (en) 4 (3H) -QUINAZOLINONES 2,3 DISSTITUTED AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
AR013875A1 (en) COMPOUND 2-IMIDAZOLINILAMINOINDOL, PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND AND USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT.
ES2190486T3 (en) 3-ACETIDINYL ALKYLPIPERIDINS OR -PIRROLIDINS AS AN TAGICININE ANTAGONISTS.
AR007088A1 (en) 2,4-DIAMINOPYRIMIDINES SUBSTITUTED, INTERMEDIATE COMPOUNDS USED IN ITS PREPARATION, PROCEDURE FOR THE PREPARATION OF SUCH 2,4-DIAMINOPYRIMIDINES CONTAINED, MEDICINES THAT CONTAIN THEM AND EMPLOYMENTS OF SUCH PIRIMIDINES
SE9901077D0 (en) Novel use
NO964121L (en) Pyrimidine or triazine carboxylic acid derivatives for use as drugs
ES2184304T3 (en) PREPARATION PROCEDURE FOR A REPLACED PERHIDRO-ISOINDOL.
PA8471301A1 (en) ARYL-CONDENSED AZAPOLYCLIC COMPOUNDS
ES2156616T3 (en) (R) -5-BROMO-N- (1-ETIL-4-METILHEXAHYDRO-1H-1,4-DIAZEPAN-6-IL) -2-METOXI-6-METHYLAMINO-3-PYRIDINCARBOXAMIDE, PROCEDURE FOR PRODUCTION AND COMPOSITION MEDICINAL CONTAINING IT.
UY24913A1 (en) 2,4-DIAMINOPYRIMIDINE SUBSTITUTED
ES2189072T3 (en) NEW BENZO-HETEROCICLIC CYCLALKINS, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
CO4410322A1 (en) NEW CARBOXAMIDE COMPOUNDS, THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
UY26147A1 (en) DERIVATIVES OF 1-TRIFLUOROMETIL-4-HIDROXI-7-PIPERIDINIL-AMINOMETILCROMANO.
PA8450901A1 (en) Erythromycin derivatives
ECSP982435A (en) 2,4- DIAMINE PIRIMIDINE SUBSTITUTED
HN2001000119A (en) S-METHYL-DIHYDRO-ZIPRASIDONE FOR THE TREATMENT OF PSYCHIATRIC AND EYE DISORDERS.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20130129